Moteur de recherche d’entreprises européennes
Financement de l’UE (1 000 000 €) : Libérer l’excellence de la recherche de l’IMM dans le domaine de l’immunité et de l’infection grâce au jumelage pour infecter Lisbonne et le Portugal grâce à son … Hor01/01/2016 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Libérer l’excellence de la recherche de l’IMM dans le domaine de l’immunité et de l’infection grâce au jumelage pour infecter Lisbonne et le Portugal grâce à son augmentation de la compétitivité et de l’innovation
TwinnToInfect will provide IMM with the opportunity to integrate the European circle of research excellence institutions by cementing a sustainable science, technology and innovation network with two internationally-leading organisations in the immunity and infection area of research, the Institut Pasteur and the Francis Crick Institute. The strategy of TwinnToInfect, based on science- and innovation-driven clustering, is focused on this societal challenge that lies at the centre of many age-related disorders. TwinnToInfect will allow: i. strengthening the science and technology capacity of IMM in immunity and infection research field; ii. and leverage its research excellence and value creation through innovation with a beneficial and quantifiable impact for the entire research and development community at IMM, the Lisbon region and Portugal. The successful implementation of this strategy will rely on specific actions, including: 1) cementing of existing and the creation of new scientific, innovative and technical collaborations through short-term staff exchanges and short-term on-site training activities; 2) training, mentoring and international exposure of IMM’s young researchers and students; 3) building an innovation ecosystem centred at IMM; 4) igniting the entrepreneurial spirit among IMM’s research community; 5) increasing science awareness among the general public through targeted dissemination and communication activities; and 6) developing a sustainability strategy to sustain the cemented network beyond project terminus. Through the completion of these activities, IMM, supported by Pasteur and Crick, is in the best temporal and spatial position to achieve an improved capability to compete for internationally competitive research funding and to access business stakeholders. By claiming its position in research and innovation networks IMM will effectively contribute to research excellence and value creation in health at European level.
| Fundacao Gimm - Gulbenkian Institute For Molecular Medicine | 893 500 € |
| Institut Pasteur | 53 250 € |
| The Francis Crick Institute Ltd. | 53 250 € |
https://cordis.europa.eu/project/id/692022
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
